Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel Holdings Inc. | 582,378 32.400% |
-19,809 (-3.29%) |
Filing History |
| 2022-02-14 4:02 pm Purchase |
2022-02-14 | 13G | BioXcel Therapeutics, Inc. BTAI |
ALLIANCEBERNSTEIN L.P. | 93,098 5.400% |
93,098 (New Position) |
Filing History |
| 2022-02-09 12:01 pm Sale |
2021-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
STATE STREET CORP STT |
84,069 4.810% |
-20,556 (-19.65%) |
Filing History |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 262,316 14.999% |
67,640 (+34.74%) |
Filing History |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 194,676 11.021% |
69,552 (+55.59%) |
Filing History |
| 2021-02-16 5:14 pm Purchase |
2020-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel Holdings Inc. | 602,188 38.590% |
602,188 (New Position) |
Filing History |
| 2021-02-11 12:52 pm Purchase |
2020-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
STATE STREET CORP STT |
104,625 6.870% |
104,625 (New Position) |
Filing History |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 125,124 8.215% |
68,212 (+119.86%) |
Filing History |